Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Sylatron

(SY-luh-tron)

A drug that is no longer available in the United States that contains the active ingredient peginterferon alfa-2b and was used to prevent melanoma from coming back after it has been removed by surgery. Sylatron is a type of cytokine and a type of immunomodulating agent.

Sylatron

Search NCI's Dictionary of Cancer Terms